Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis

dc.contributor.author	Ruiz-López, Francisco-José
dc.contributor.author	Blanquer-Blanquer, Miguel
dc.date.accessioned	2026-10-21T06:04:46Z
dc.date.available	2026-10-21T06:04:46Z
dc.date.issued	2016
dc.identifier.citation	Fujikawa A, Noda M. Role of pleiotrophin-protein tyrosine phosphatase receptor type Z signaling in myelination. Neural Regen Res. 2016;11(4):549. doi:10.4103/1673-5374.180730
dc.identifier.issn	1673-5374
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/28645
dc.language.iso	eng
dc.rights	Atribución/Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional
dc.rights.uri	https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es	*
dc.title	Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis
dc.type	info:eu-repo/semantics/article
dc.identifier.pmid	27212914
dc.relation.publisherversion	https://journals.lww.com/10.4103/1673-5374.180730
dc.identifier.doi	10.4103/1673-5374.180730
dc.journal.title	Neural Regeneration Research
dc.identifier.essn	1876-7958